PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin

This partnership will meet market needs with quality, value and flexibility.

Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin
2010-08-09
SAN FRANCISCO, CA, August 09, 2010 (Press-News.org) Lampire Biological Laboratories (LBL) announced today that it signed an agreement with Proliant Health and Biologicals (Proliant), manufacturer of the worlds most trusted, high quality Bovine Serum Albumin (BSA), to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.

Stephen Welch, President & CEO of Proliant, said, "Proliant has become the pre-eminent bulk manufacturer of BSA, currently supplying over half of global demand. As part of this rapid growth, Proliant is committed to supplying customers who require smaller quantities of BSA the same value large scale customers enjoy, plus a greater degree of flexibility and customer service." Stephen went on to say, "The search is now over; Lampire with its contract manufacturing abilities, plus an extensive knowledge of the diagnostic and pharmaceutical industries, fulfills every attribute Proliant requires."

According to Gregory F. Krug, President & CEO of LBL, "The applications for BSA are truly endless and we are proud to enter into this strategic partnership with Proliant." Greg went on to say, "...we are looking at drug development labs, academic research institutes, biotech companies and antibody suppliers all of which need high quality BSA. The Lampire Business Model will allow us to provide them with high quality BSA in a variety of forms and formulations in a most cost-effective manner."

About Lampire Biological Laboratories
Lampire Biological Laboratories specializes in polyclonal and monoclonal antibody development, cell culture devices and services, and a wide variety of blood-derived products. Founded in 1977, the Pennsylvania based company offers an extensive line of secondary antibodies, purified IgGs, human and animal blood products, plus a comprehensive line of animal tissues and organs. The latest product and service releases include novel teratogenicity screening assays, New Zealand sourced animal blood products, the gas-permeable LAMPIRE OMNI C3 Cell Culture Bag, exclusive antibodies to chemotherapeutic agents, and Proliant BSA. Additional services include peptide synthesis, antigen design, antibody purification, custom conjugation, immunoassay development, and contract manufacturing. Lampire is a privately held company.

About Proliant Health and Biologicals
Proliant, a privately held company, is the world's largest producer of bovine plasma derivatives, such as BSA. Derived from the plasma of healthy, US-origin animals with complete traceability, Proliant's bovine serum albumin exceeds 99% purity and is suitable for diagnostic, pharmaceutical, veterinary, and research applications.

Proliant Health and Biologicals specializes in the development of ingredients from natural sources for the human health and nutrition industry, including the dietary supplement, clinical nutrition, consumer health and functional food markets. Proliant has developed exciting new technologies to isolate bio-active proteins and peptides that play vital roles in human health. The most well-known of these are immunoglobulins.

Proliant ingredients are unsurpassed in innovation and quality, which allows them to be used in the most sensitive nutritional applications. ImmunoLin is an immunoglobulin protein isolate which can be used for tablets, capsules, drink mixes, lozenges and bars.

Contacts:

Lampire Biological Laboratories
Gregory F. Krug
President
Office: 215-795-2838
Website: http://www.proliantinc.com

or

Proliant Health & Biologicals
Jim Torvik
Director of Sales and Marketing
Office: 515-289-5142
Mobile: 515-494-0700

[Attachments] See images for this press release:
Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin

ELSE PRESS RELEASES FROM THIS DATE:

Whataburger Asks Customers: "Tell Us Why You're Our Biggest Fan!"

Whataburger Asks Customers: Tell Us Why Youre Our Biggest Fan!
2010-08-09
Southern burger icon Whataburger celebrates its 60th anniversary with its "Tell Us Why You're Our Biggest Fan" online contest. At stake is a Whataburger fan's dream come true: 60 years of free Whataburger, a trip to the Whataburger convention in Dallas, TX and other cool prizes! Beginning August 4 and all throughout the company's anniversary month of August, fans can submit either videos or essays with photos at www.whataburger.com, demonstrating why they are Whataburger's biggest fans. The first 60 fans to enter will win a coupon for a free Whataburger. The contest ...

LAST 30 PRESS RELEASES:

A graphene sandwich — deposited or transferred?

New light-powered motor fits inside a strand of hair

Oil rig study reveals vital role of tiny hoverflies

Children’s Hospital of Philadelphia researchers boost widespread use of dental varnish across pediatric network

iRECODE: A new computational method that brings clarity to single-cell analysis

New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey

QUT scientists create material to turn waste heat into clean power

Major new report sets out how to tackle the ‘profound and lasting impact’ of COVID-19 on cardiovascular health

Cosmic crime scene: White dwarf found devouring Pluto-like icy world

Major report tackles Covid’s cardiovascular crisis head-on

A third of licensed GPs in England not working in NHS general practice

ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle

Engineers uncover why tiny particles form clusters in turbulent air

GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

Psoriasis linked to increased risk of vision-threatening eye disease, study finds

Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity

Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests

Resistance training may improve nerve health, slow aging process, study shows

Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer

SwRI-built instruments to monitor, provide advanced warning of space weather events

Breakthrough advances sodium-based battery design

New targeted radiation therapy shows near-complete response in rare sarcoma patients

Does physical frailty contribute to dementia?

Soccer headers and brain health: Study finds changes within folds of the brain

Decoding plants’ language of light

UNC Greensboro study finds ticks carrying Lyme disease moving into western NC

New implant restores blood pressure balance after spinal cord injury

New York City's medical specialist advantage may be an illusion, new NYU Tandon research shows

Could a local anesthetic that doesn’t impair motor function be within reach?

1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5

[Press-News.org] Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin
This partnership will meet market needs with quality, value and flexibility.